Pimecrolimus and dual pimecrolimus-paclitaxel eluting stents decrease neointimal proliferation in a porcine model
- 11 October 2007
- journal article
- research article
- Published by Wiley in Catheterization and Cardiovascular Interventions
- Vol. 70 (6), 871-879
- https://doi.org/10.1002/ccd.21299
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Discovery of Topical Calcineurin Inhibitors and Pharmacological Profile of PimecrolimusInternational Archives of Allergy and Immunology, 2006
- Inflammatory cell numbers and cytokine expression in atopic dermatitis after topical pimecrolimus treatmentAllergy, 2005
- Survival of Endothelial Cells in vitro on Paclitaxel-loaded Coronary StentsJournal of Biomaterials Applications, 2005
- Endothelial dysfunction and inflammation after percutaneous coronary interventionThe American Journal of Cardiology, 2004
- Rapamycin inhibits proliferation and differentiation of human endothelial progenitor cells in vitroExperimental Cell Research, 2004
- Evaluation of a high-dose dexamethasone-eluting stentThe American Journal of Cardiology, 2004
- Sirolimus-Eluting Stents versus Standard Stents in Patients with Stenosis in a Native Coronary ArteryNew England Journal of Medicine, 2003
- Stent-Induced Expression and Activation of the Leukocyte Integrin Mac-1 Is Associated With Neointimal Thickening and RestenosisCirculation, 2003
- Macrolactam immunomodulators for topical treatment of inflammatory skin diseasesJournal of the American Academy of Dermatology, 2001
- GLUCOCORTICOID SUPPRESSION OF MACROPHAGE MIGRATION INHIBITORY FACTORThe Journal of Experimental Medicine, 1973